LMATNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
LEMAITRE VASCULAR INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$82.31+1.49 (+1.84%)
Close on Oct 19, 2026
- Market cap
- $2.02B
- P/E (TTM)
- 28.9
- Dividend yield
- 0.97%
LEMAITRE VASCULAR INC revenue by segment
By business segment
By product or service
By region
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $145.72M | $144.12M | $141.57M | $138.80M | $136.10M | $132.25M | $128.74M | $125.49M | $122.40M | $119.92M | $117.81M | $112.87M | 55.5% | +7.1% |
| Other countries | $66.57M | $63.92M | $61.67M | $58.38M | $56.43M | $53.77M | $52.07M | $49.50M | $47.31M | $45.45M | $42.91M | $41.80M | 25.4% | +18.0% |
| Germany | $20.34M | $19.46M | $17.90M | $16.42M | $15.83M | $14.88M | $14.42M | $14.09M | $13.52M | $13.59M | $13.42M | $12.79M | 7.8% | +28.5% |
| Canada | $16.18M | $15.58M | $15.25M | $14.61M | $14.12M | $13.78M | $13.67M | $13.26M | $12.54M | $11.64M | $10.79M | $10.29M | 6.2% | +14.6% |
| United Kingdom | $13.62M | $13.19M | $13.22M | $12.66M | $12.16M | $11.58M | $10.96M | $10.69M | $9.86M | $9.29M | $8.56M | $7.81M | 5.2% | +12.0% |
| Americas | – | – | – | – | – | – | $144.58M | $140.77M | $136.83M | $133.43M | $130.31M | $124.91M | – | – |
| Asia Pacific | – | – | – | – | – | – | $15.31M | $14.65M | $13.86M | $13.24M | $12.08M | $11.78M | – | – |
| Europe, Middle East and Africa | – | – | – | – | – | – | $59.97M | $57.61M | $54.94M | $53.22M | $51.10M | $48.87M | – | – |
From the segment and revenue-disaggregation notes of Lemaitre Vascular's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.